carbamazepine has been researched along with Bone Diseases, Metabolic in 11 studies
Carbamazepine: A dibenzazepine that acts as a sodium channel blocker. It is used as an anticonvulsant for the treatment of grand mal and psychomotor or focal SEIZURES. It may also be used in the management of BIPOLAR DISORDER, and has analgesic properties.
carbamazepine : A dibenzoazepine that is 5H-dibenzo[b,f]azepine carrying a carbamoyl substituent at the azepine nitrogen, used as an anticonvulsant.
Bone Diseases, Metabolic: Diseases that affect the METABOLIC PROCESSES of BONE TISSUE.
| Excerpt | Relevance | Reference |
|---|---|---|
| " The aim of this study is to determine the effect of oxcarbazepine (OXC) monotherapy on biochemical markers of bone metabolism and BMD in epilepsy patients." | 7.80 | Effect of oxcarbazepine on bone mineral density and biochemical markers of bone metabolism in patients with epilepsy. ( Han, SW; Hong, SB; Hwang, KJ; Joo, EY; Kim, JY; Koo, DL; Lee, HW; Seo, DW; Shin, WC, 2014) |
| " The aim of this study is to determine the effect of oxcarbazepine (OXC) monotherapy on biochemical markers of bone metabolism and BMD in epilepsy patients." | 3.80 | Effect of oxcarbazepine on bone mineral density and biochemical markers of bone metabolism in patients with epilepsy. ( Han, SW; Hong, SB; Hwang, KJ; Joo, EY; Kim, JY; Koo, DL; Lee, HW; Seo, DW; Shin, WC, 2014) |
| " We previously reported biochemical evidence of increased bone turnover in premenopausal women with epilepsy on phenytoin monotherapy compared with those on carbamazepine, lamotrigine, and valproate." | 3.74 | Bone health in young women with epilepsy after one year of antiepileptic drug monotherapy. ( McMahon, DJ; Morrell, MJ; Pack, AM; Randall, A; Shane, E, 2008) |
| "To study the markers of bone turnover in epilepsy patients in the different stages of the pubertal growth before and after the beginning of carbamazepine (CBZ) monotherapy." | 3.71 | Increased bone turnover in prepubertal, pubertal, and postpubertal patients receiving carbamazepine. ( Chiarelli, F; Greco, R; Latini, G; Morgese, G; Verrotti, A, 2002) |
| "Drug-induced osteopenia was evident in 3 patients with z scores of bone-mineral density less than -2." | 2.73 | Evaluation of bone turnover in epileptic children using oxcarbazepine. ( Camurdan, O; Cansu, A; Cinaz, P; Gücüyener, K; Gülbahar, O; Hirfanoğlu, TL; Serdaroğlu, A; Yesilkaya, E, 2008) |
| "The severe sole effects of seizures on the cortical part of bone were reported in our previous study." | 1.48 | Side-Effects of Convulsive Seizures and Anti-Seizure Therapy on Bone in a Rat Model of Epilepsy. ( Boskey, AL; Evis, Z; Garip Ustaoglu, S; Ilbay, G; Severcan, F, 2018) |
| "For patients with mental retardation or developmental delay, 25(OH)D3 levels were lower than the levels in patients with normal intelligence quotient levels (p=0." | 1.40 | Vitamin D levels in children and adolescents with antiepileptic drug treatment. ( Baek, JH; Eun, BL; Kim, GH; Kim, MK; Seo, YH, 2014) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (9.09) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 7 (63.64) | 29.6817 |
| 2010's | 3 (27.27) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Garip Ustaoglu, S | 1 |
| Evis, Z | 1 |
| Ilbay, G | 1 |
| Boskey, AL | 1 |
| Severcan, F | 1 |
| Koo, DL | 1 |
| Hwang, KJ | 1 |
| Han, SW | 1 |
| Kim, JY | 1 |
| Joo, EY | 1 |
| Shin, WC | 1 |
| Lee, HW | 2 |
| Seo, DW | 1 |
| Hong, SB | 1 |
| Baek, JH | 1 |
| Seo, YH | 1 |
| Kim, GH | 1 |
| Kim, MK | 1 |
| Eun, BL | 1 |
| Cansu, A | 1 |
| Yesilkaya, E | 1 |
| Serdaroğlu, A | 1 |
| Hirfanoğlu, TL | 1 |
| Camurdan, O | 1 |
| Gülbahar, O | 1 |
| Gücüyener, K | 1 |
| Cinaz, P | 1 |
| Cetinkaya, Y | 1 |
| Kurtulmuş, YS | 1 |
| Tutkavul, K | 1 |
| Tireli, H | 1 |
| Sheth, RD | 1 |
| Verrotti, A | 1 |
| Greco, R | 1 |
| Latini, G | 1 |
| Morgese, G | 1 |
| Chiarelli, F | 1 |
| Kim, SH | 1 |
| Lee, JW | 1 |
| Choi, KG | 1 |
| Chung, HW | 1 |
| Pack, AM | 1 |
| Morrell, MJ | 1 |
| Randall, A | 1 |
| McMahon, DJ | 1 |
| Shane, E | 1 |
| Tsukahara, H | 1 |
| Kimura, K | 1 |
| Todoroki, Y | 1 |
| Ohshima, Y | 1 |
| Hiraoka, M | 1 |
| Shigematsu, Y | 1 |
| Tsukahara, Y | 1 |
| Miura, M | 1 |
| Mayumi, M | 1 |
| Schapira, D | 1 |
| Barron, SA | 1 |
| Nahir, M | 1 |
| Scharf, Y | 1 |
1 trial available for carbamazepine and Bone Diseases, Metabolic
| Article | Year |
|---|---|
Evaluation of bone turnover in epileptic children using oxcarbazepine.
Topics: Administration, Oral; Adolescent; Alkaline Phosphatase; Anticonvulsants; Biomarkers; Bone Density; B | 2008 |
10 other studies available for carbamazepine and Bone Diseases, Metabolic
| Article | Year |
|---|---|
Side-Effects of Convulsive Seizures and Anti-Seizure Therapy on Bone in a Rat Model of Epilepsy.
Topics: Animals; Anticonvulsants; Bone and Bones; Bone Density; Bone Diseases, Metabolic; Calcium; Carbamaze | 2018 |
Effect of oxcarbazepine on bone mineral density and biochemical markers of bone metabolism in patients with epilepsy.
Topics: Absorptiometry, Photon; Adolescent; Adult; Analysis of Variance; Anticonvulsants; Bone Density; Bone | 2014 |
Vitamin D levels in children and adolescents with antiepileptic drug treatment.
Topics: Adolescent; Anticonvulsants; Bone Density; Bone Diseases, Metabolic; Carbamazepine; Child; Child, Pr | 2014 |
The effect of oxcarbazepine on bone metabolism.
Topics: Absorptiometry, Photon; Adolescent; Adult; Alkaline Phosphatase; Anticonvulsants; Bone and Bones; Bo | 2009 |
Bone health in epilepsy.
Topics: Adolescent; Anticonvulsants; Bone Diseases, Metabolic; Carbamazepine; Cytochrome P-450 Enzyme System | 2002 |
Increased bone turnover in prepubertal, pubertal, and postpubertal patients receiving carbamazepine.
Topics: Adolescent; Adult; Age Factors; Anticonvulsants; Biomarkers; Bone Diseases, Metabolic; Bone Resorpti | 2002 |
A 6-month longitudinal study of bone mineral density with antiepileptic drug monotherapy.
Topics: Adolescent; Adult; Anticonvulsants; Biomarkers; Bone Density; Bone Diseases, Metabolic; Calcitriol; | 2007 |
Bone health in young women with epilepsy after one year of antiepileptic drug monotherapy.
Topics: Adolescent; Adult; Alkaline Phosphatase; Anticonvulsants; Biomarkers; Bone Density; Bone Diseases, M | 2008 |
Bone mineral status in ambulatory pediatric patients on long-term anti-epileptic drug therapy.
Topics: Absorptiometry, Photon; Adolescent; Anticonvulsants; Biomarkers; Bone Density; Bone Diseases, Metabo | 2002 |
Reflex sympathetic dystrophy syndrome coincident with acute diabetic neuropathy.
Topics: Bone Diseases, Metabolic; Carbamazepine; Diabetic Neuropathies; Female; Humans; Middle Aged; Reflex | 1988 |